5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft

Alexandra Borodovsky(Johns Hopkins Medicine), Gregory J. Riggins(Johns Hopkins University)
Oncotarget
September 16, 2013
Cited by 155


Related Papers